Skip to main content
. 2018 Jul 4;362:k2505. doi: 10.1136/bmj.k2505

Fig 5.

Fig 5

Patients with and without atrial fibrillation: adjusted Cox hazard ratios (95% confidence interval) for outcomes associated with exposure to study drugs compared with apixaban. NA=not available. *P value<0.01. †The results were only available from the QResearch database.